|
1
|
Ganz PA and Goodwin PJ: Breast cancer
survivorship: Where are we today? Adv Exp Med Biol. 862:1–8. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Waks AG and Winer EP: Breast cancer
treatment: A review. JAMA. 321:288–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang X, Li Y, Zhou Y, Mao F, Lin Y, Guan
J and Sun Q: Diagnostic performance of indocyanine green-guided
sentinel lymph node biopsy in breast cancer: A meta-analysis. PLoS
One. 11:e01555972016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosenberg SM and Partridge AH: Management
of breast cancer in very young women. Breast. 24(Suppl 2):
S154–S158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Lin Y, Yang X, Wu X and He X: Long
noncoding RNA H19 regulates EZH2 expression by interacting with
miR-630 and promotes cell invasion in nasopharyngeal carcinoma.
Biochem Biophys Res Commun. 473:913–919. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thornton JE and Gregory RI: How does Lin28
let-7 control development and disease? Trends Cell Biol.
22:474–482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang H, Zhao Q, Deng K, Guo X and Xia J:
Lin28: An emerging important oncogene connecting several aspects of
cancer. Tumour Biol. 37:2841–2848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saitoh M: Involvement of partial EMT in
cancer progression. J Biochem. 164:257–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo S, Liang X, Guo M, Zhang X and Li Z:
Migration inhibition of water stress proteins from nostoc commune
vauchvia. activation of autophagy in DLD-1 cells. Int J Biol
Macromol. 119:669–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou WH, Tang F, Xu J, Wu X, Yang SB, Feng
ZY, Ding YG, Wan XB, Guan Z, Li HG, et al: Low expression of beclin
1, associated with high Bcl-xL, predicts a malignant phenotype and
poor prognosis of gastric cancer. Autophagy. 8:389–400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang C, Xu J, Meng Q, Zhang B, Liu J, Hua
J, Zhang Y, Shi S and Yu X: TGFB1-induced autophagy affects the
pattern of pancreatic cancer progression in distinct ways depending
on SMAD4 status. Autophagy. 17:1–15. 2019.
|
|
15
|
Lv Q, Wang W, Xue J, Hua F, Mu R, Lin H,
Yan J, Lv X, Chen X and Hu ZW: DEDD interacts with PI3KC3 to
activate autophagy and attenuate epithelial-mesenchymal transition
in human breast cancer. Cancer Res. 72:3238–3250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang
M, Zhang B, Yang B, Li B, Yang H and Wu Y: Inhibition of autophagy
promotes metastasis and glycolysis by inducing ROS in gastric
cancer cells. Oncotarget. 6:39839–39854. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Zhou J, Yang L, Zhong T, Mueller M, Men Y,
Zhang N, Xie J, Giang K, Chung H, Sun X, et al: H19 lncRNA alters
DNA meth-ylation genome wide by regulating S-adenosylhomocysteine
hydrolase. Nat Commun. 6:102212015. View Article : Google Scholar
|
|
19
|
Wang L, Yuan C, Lv K, Xie S, Fu P, Liu X,
Chen Y, Qin C, Deng W and Hu W: Lin28 mediates radiation resistance
of breast cancer cells via regulation of caspase, H2A.X and Let-7
signaling. PLoS One. 8:e673732013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gonzalez DM: Medici D. Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG and
Weiss SJ: Canonical Wnt signaling regulates Slug activity and links
epithelial-mesenchymal transition with epigenetic breast cancer 1,
early onset (BRCA1) repression. Proc Natl Acad Sci USA.
109:16654–16659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes LV, Tate CR, Segar HC, Burks HE,
Phamduy TB, Hoang V, Elliott S, Gilliam D, Pounder FN, Anbalagan M,
et al: Suppression of triple-negative breast cancer metastasis by
pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT
master regulators. Breast Cancer Res Treat. 145:593–604. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu
L, Tang X, Du YE, Hu P and Liu M: Twist induces
epithelial-mesenchymal transition and cell motility in breast
cancer via ITGB1-FAK/ILK signaling axis and its associated
downstream network. Int J Biochem Cell Biol. 71:62–71. 2016.
View Article : Google Scholar
|
|
25
|
Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim
NH, Cha SY, Ryu JK, Choi YJ, Kim J, et al: A Wnt-Axin2-GSK3beta
cascade regulates snail1 activity in breast cancer cells. Nat Cell
Biol. 8:1398–1406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weyemi U, Redon CE, Sethi TK, Burrell AS,
Jailwala P, Kasoji M, Abrams N, Merchant A and Bonner WM: Twist1
and Slug mediate H2AX-regulated epithelial-mesenchymal transition
in breast cells. Cell Cycle. 15:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou Q, Wu H, Fu F, Yi W, Pei L and Zhou M:
RKIP suppresses the proliferation and metastasis of breast cancer
cell lines through up-regulation of miR-185 targeting HMGA2. Arch
Biochem Biophys. 610:25–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Felipe Lima J, Nofech-Mozes S, Bayani J
and Bartlett JM: EMT in breast carcinoma-a review. J Clin Med.
5:E652016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lamouille S, Connolly E, Smyth JW, Akhurst
RJ and Derynck R: TGF-β-induced activation of mTOR complex 2 drives
epithelial-mesenchymal transition and cell invasion. J Cell Sci.
125:1259–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Ye C, Xiong H, Shen Y, Lu Y, Zhou
J and Wang L: Dysregulation of long non-coding RNA in breast
cancer: An overview of mechanism and clinical implication.
Oncotarget. 8:5508–5522. 2017.
|
|
31
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Imig J, Brunschweiger A, Brümmer A,
Guennewig B, Mittal N, Kishore S, Tsikrika P, Gerber AP, Zavolan M
and Hall J: miR-CLIP capture of a miRNA targetome uncovers a
lincRNA H19-miR-106a interaction. Nat Chem Biol. 11:107–114. 2015.
View Article : Google Scholar
|
|
34
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar
|
|
36
|
Balzeau J, Menezes MR, Cao S and Hagan JP:
The LIN28/let-7 pathway in cancer. Front Genet. 8:312017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang S and Baltimore D: RNA-binding
protein Lin28 in cancer and immunity. Cancer Lett. 375:108–113.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cui C, Li Z and Wu D: The long non-coding
RNA H19 induces hypoxia/reoxygenation injury by up-regulating
autophagy in the hepatoma carcinoma cells. Biol Res. 52:322019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang M, Han D, Yuan Z, Hu H, Zhao Z, Yang
R, Jin Y, Zou C, Chen Y, Wang G, et al: Long non-coding RNA H19
confers 5-Fu resistance in colorectal cancer by promoting
SIRT1-mediated autophagy. Cell Death Dis. 9:11492018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Xie S, Yang J, Xiong H, Jia Y,
Zhou Y, Chen Y, Ying X, Chen C, Ye C, et al: The long noncoding RNA
H19 promotes tamoxifen resistance in breast cancer via autophagy. J
Hematol Oncol. 12:812019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Liu CY, Wan Y, Peng L, Li WF and
Qiu JX: Long non-coding RNA H19 promotes the proliferation of
fibroblasts in keloid scarring. Oncol Lett. 12:2835–2839. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhuo C, Jiang R, Lin X and Shao M: LncRNA
H19 inhibits autophagy by epigenetically silencing of DIRAS3 in
diabetic cardiomyopathy. Oncotarget. 8:1429–1437. 2017. View Article : Google Scholar :
|
|
43
|
Xu Z, Yan Y, Qian L and Gong Z: Long
non-coding RNAs act as regulators of cell autophagy in diseases
(review). Oncol Rep. 37:1359–1366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo Q, Jing FJ, Xu W, Li X, Li X, Sun JL,
Xing XM, Zhou CK and Jing FB: Ubenimex induces autophagy inhibition
and EMT suppression to overcome cisplatin resistance in GC cells by
perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis. Aging. 11:2019.
|
|
46
|
Liang F, Ren C, Wang J, Wang S, Yang L,
Han X, Chen Y, Tong G and Yang G: The crosstalk between STAT3 and
p53/RAS signaling controls cancer cell metastasis and cisplatin
resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT
and autophagy. Oncogenesis. 8:592019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Han LL, Jia L, Wu F and Huang C: Sirtuin6
(SIRT6) promotes the EMT of hepatocellular carcinoma by stimulating
autophagic degradation of E-cadherin. molecular cancer research:
Mol Cancer Res. 17:2267–2280. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang Z, Jones R, Liu JC, Deng T, Robinson
T, Chung PE, Wang S, Herschkowitz JI, Egan SE, Perou CM and
Zacksenhaus E: RB1 and p53 at the crossroad of EMT and
triple-negative breast cancer. Cell Cycle. 10:1563–1570. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dhamija S and Diederichs S: From junk to
master regulators of invasion: lncRNA functions in migration, EMT
and metastasis. Int J Cancer. 139:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jin B, Wang W, Meng XX, Du G, Li J, Zhang
SZ, Zhou BH and Fu ZH: Let-7 inhibits self-renewal of
hepatocellular cancer stem-like cells through regulating the
epithelial-mesenchymal transition and the Wnt signaling pathway.
BMC Cancer. 16:8632016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Qiu XY, Hu DX, Chen WQ, Chen RQ, Qian SR,
Li CY, Li YJ, Xiong XX, Liu D, Pan F, et al: PD-L1 confers
glioblastoma multi-forme malignancy via Ras binding and Ras/Erk/EMT
activation. Biochim Biophys Acta Mol Basis Dis. 1864:1754–1769.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hu F, Zhao Y, Yu Y, Fang JM, Cui R, Liu
ZQ, Guo XL and Xu Q: Docetaxel-mediated autophagy promotes
chemoresistance in castration-resistant prostate cancer cells by
inhibiting STAT3. Cancer Lett. 416:24–30. 2018. View Article : Google Scholar
|
|
54
|
Sosa P, Alcalde-Estevez E, Plaza P,
Troyano N, Alonso C, Martínez-Arias L, Evelem de Melo Aroeira A,
Rodriguez-Puyol D, Olmos G, López-Ongil S and Ruíz-Torres MP:
Hyperphosphatemia promotes senescence of myoblasts by impairing
autophagy through Ilk overexpression, a possible mechanism involved
in sarcopenia. Aging Dis. 9:769–784. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang M and Xin W: Matrine inhibiting
pancreatic cells epithelial-mesenchymal transition and invasion
through ROS/NF-κB/MMPs pathway. Life Sci. 192:55–61. 2018.
View Article : Google Scholar
|
